News and Events
Stem cell–derived natural killer cells engineered to attack solid tumors
Cancer-killing natural killer cells could pave the way to off-the-shelf immunotherapy for solid tumors.
Read More
Clinical trial researching prostate cancer in African American adults
Ismail Baris Turkbey, M.D., Senior Clinician in the Molecular Imaging Branch, is leading a clinical trial to study and improve diagnostic outcomes for prostate cancer in African American adults.
Read More
In Memoriam: C. Norman Coleman, M.D.
The CCR community is deeply saddened by the recent passing of C. Norman Coleman, M.D., Senior Investigator in the Radiation Oncology Branch.
Read More
New Milestones publication now available
Every year, CCR makes remarkable contributions to the understanding, detection, treatment and prevention of cancer. This issue of our annual publication, Milestones, features 10 of our top scientific advances from the past year. These discoveries fall everywhere on the spectrum from basic science to clinical research, ranging from a change in our understanding of how cells replicate and divide to the first FDA-approved treatment for a rare cancer based on the results of an NCI trial. Our researchers have developed a novel drug delivery system inspired by bacterial spores, identified prognostic gene signatures for patients with different cancers and gathered data over 30 years to show that an immunotherapy essentially cures a rare precancerous disease.
Read More
New research on liver cell diversity could help scientists understand tumor complexity
Hepatocytes, the main cell type in the liver, differ in function according to their location in the liver. A new study shows that mitochondrial responses to nutrients drive this diversity — a finding that could help researchers better understand tumor cell heterogeneity.
Read More
Clinical trial researching therapy for esophageal cancers
A clinical trial led by David S. Schrump, M.D., MBA., FACS, Chief and Senior Investigator in the Thoracic Surgery Branch, is researching a combination vaccine and drug therapy for esophageal cancers.
Read More
New biomaterial enhances cancer vaccine effectiveness to help eliminate cancer in mice
Scientists have created a new type of cancer vaccine approach that uses a biomaterial that attracts immune cells and localizes the delivery of the vaccines. In mice, the biomaterial combined with a cancer vaccine was able to cure 50 to 75% of their tumors.
Read More
Steven Rosenberg receives AACR Award for Lifetime Achievement in Cancer Research
The American Association for Cancer Research (AACR) has awarded Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, the AACR Award for Lifetime Achievement in Cancer Research. He is being recognized for his paramount contributions to cancer research and patient care, most notably his pioneering research in establishing cancer immunotherapy as a major treatment strategy for many cancer types. He will receive the award at the 2024 AACR Annual Meeting.
Read More
Clinical trial researching BRCA1-Associated Protein-1 mutations
A clinical trial led by David S. Schrump, M.D., M.B.A., FACS, Chief and Senior Investigator in the Thoracic Surgery Branch, is researching a combination drug therapy for BRCA1-Associated Protein-1 mutations.
Read More
Clinical trial researching therapy for B-cell lymphoma
A clinical trial led by Kathryn A. Lurain, M.D., M.P.H., Assistant Research Physician in the HIV and AIDS Malignancy Branch, is researching a drug for B-cell lymphoma.
Read More
Celebrating CCR Careers: Jonathan R. Keller, Ph.D.
Jonathan R. Keller, Ph.D., an experimental hematologist who discovered interleukin-3 (IL-3) and explored the factors that give rise to leukemia, announces his retirement.
Read More